Zeus Opens State-of-the-Art Facility

Zeus, a global leader in advanced polymer solutions, announced today that construction is almost complete on a state-of-the-art catheter manufacturing facility in Arden Hills, Minnesota. The location, scale, and on-site capabilities across R&D, design, and development will advance catheter innovation and strengthen Zeus’s strategic partnerships with OEMs and medical device customers.

“The Minnesota facility is an important step in our geographic expansion for several reasons,” said Steve Peterson, President and CEO of Zeus. “The state has a long track record in medical device innovation, and locating closer to customers will support deeper collaboration across early-stage catheter design and development. Furthermore, this facility allows us to scale catheter manufacturing significantly to meet growing global customer and market demand.”

Scheduled to open in summer 2023, this custom 75,600 square feet facility includes an advanced R&D lab and cleanroom equipped with the latest technologies to design, develop, and validate new catheter prototypes in industry-best lead times. It also brings additional capabilities in-house to Zeus, including laser cutting, ablation, and welding.

“This facility opens the door to expanding our end-to-end catheter design and manufacturing capabilities, all under one roof. It’s a big step for our customers and the industry,” said Suresh Sainath, General Manager for Zeus’ catheter solutions division. “It also represents a building block for future strategic collaboration between our catheter and polymer customers, enabling industry-defining catheter innovation going forward.”

As well as proximity to current customers, the Arden Hills, MN, location was selected for its easy access to local transportation and amenities for the company’s expanding workforce. Following an agreement with DEED as part of the Minnesota Job Creation Fund (JCF), this new facility is expected to create 100-plus new jobs in the coming years. Positions will include engineers, project managers, technicians, and product builders.

SourceZeus

Hot this week

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.